Amerise Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 5, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	49	39	60	44	46	90
Market Cap Growth	-15.91%	-35.16%	37.88%	-5.71%	-48.53%	-17.58%
Enterprise Value	43	39	60	45	46	90
Last Close Price	0.74	0.59	0.91	0.66	0.70	1.36
PE Ratio	281.80	242.12	1054.79	-	-	16.36
PS Ratio	19.16	15.28	31.98	121.46	525.55	0.94
PB Ratio	0.91	0.72	1.12	0.81	0.84	1.59
P/TBV Ratio	0.91	0.72	1.12	0.81	0.84	1.59
P/OCF Ratio	-	-	1.96	-	-	146.34
EV/Sales Ratio	16.84	15.18	31.90	124.09	524.95	0.94
EV/EBIT Ratio	208.60	188.08	768.77	-	-	16.32
Debt / Equity Ratio	-	-	-	-	0.02	0.02
Net Debt / Equity Ratio	-0.11	-0.11	0.00	0.00	0.01	0.01
Asset Turnover	0.03	0.03	0.03	0.01	0.00	1.09
Quick Ratio	0.29	0.29	0.01	1.36	0.37	0.99
Current Ratio	0.30	0.30	0.01	1.48	0.37	0.99
Return on Equity (ROE)	0.30%	0.30%	0.11%	-2.68%	-2.13%	10.24%
Return on Assets (ROA)	0.16%	0.16%	0.07%	-1.65%	-1.18%	3.90%
Return on Invested Capital (ROIC)	0.32%	0.32%	0.11%	-2.66%	-2.93%	10.12%
Return on Capital Employed (ROCE)	0.40%	0.40%	0.10%	-2.70%	-3.00%	9.60%
Earnings Yield	0.33%	0.41%	0.10%	-3.35%	-2.57%	6.11%
Buyback Yield / Dilution	7.22%	7.22%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.